Treat elderly patients hospitalized for community-acquired pneumonia early based on infection severity and risk factors

Treat elderly patients hospitalized for community-acquired pneumonia early based on infection... Community-acquired pneumonia is a frequent cause of morbidity and mortality in the elderly. Antimicrobial treatment should be initiated before the patient leaves the emergency department. Treatment is empirical and should cover typical pathogens and, if patient risk is identified, also atypical pathogens such as meticillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Special concerns in the elderly include the increased risk of adverse drug effects and comorbidity exacerbation. As prevention is ideal, patients should receive appropriate pneumococcus and influenza vaccinations. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drugs & Therapy Perspectives Springer Journals

Treat elderly patients hospitalized for community-acquired pneumonia early based on infection severity and risk factors

Loading next page...
 
/lp/springer_journal/treat-elderly-patients-hospitalized-for-community-acquired-pneumonia-2YlzXlZt6Z
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Pharmacy; Pharmacy; Pharmacotherapy
ISSN
1172-0360
eISSN
1179-1977
D.O.I.
10.1007/s40267-017-0430-x
Publisher site
See Article on Publisher Site

Abstract

Community-acquired pneumonia is a frequent cause of morbidity and mortality in the elderly. Antimicrobial treatment should be initiated before the patient leaves the emergency department. Treatment is empirical and should cover typical pathogens and, if patient risk is identified, also atypical pathogens such as meticillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Special concerns in the elderly include the increased risk of adverse drug effects and comorbidity exacerbation. As prevention is ideal, patients should receive appropriate pneumococcus and influenza vaccinations.

Journal

Drugs & Therapy PerspectivesSpringer Journals

Published: Jul 12, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off